Ea. Engleman et al., OPERANT RESPONSE SUPPRESSION INDUCED WITH SYSTEMIC ADMINISTRATION OF 5-HYDROXYTRYPTOPHAN IS CENTRALLY MEDIATED, Pharmacology, biochemistry and behavior, 52(3), 1995, pp. 525-529
Intracerebroventricular (ICV) administration of selective serotonergic
agents was used to examine the extent of central mediation of 5-HTP-i
nduced operant response suppression in rats. ICV administration of LY5
3857 (1.0, 3.75, or 7.5 mu g/5 mu l/5 min) dose dependently blocked re
sponse suppression induced with systemically administered 5-HTP (25 mg
/kg, IP), whereas ICV 0.9% saline (5 mu l over 5 min) had no significa
nt effect on 5-HTP-induced response suppression. ICV ketanserin (7.5 m
u g/5 mu l/5 min) also blocked response suppression induced with syste
mically administered 5-HTP. ICV administration of the 5-HT2A/2C recept
or agonist DOI (80 mu g/5 mu l/5 min) induced significant periods of r
esponse suppression in this model, which was blocked with LY53857 (1.0
mg/kg, IF) pretreatment. These data demonstrate that central administ
ration of 5-HT2A/2C antagonists potently attenuate operant response su
ppression induced with systemically administered 5-HTP or DOI and are
in agreement with previous findings suggesting central mediation of 5-
HTP-induced operant response suppression.